ArticleJournal of the National Cancer Institute2012

Selective inhibition of HER2-positive breast cancer cells by the HIV protease inhibitor nelfinavir.

Joong Sup Shim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.